Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease

NCT00959972 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: Varenicline
DRUG: Transdermal Nicotine Patch

Sponsor

Ottawa Heart Institute Research Corporation

Collaborators

[object Object]